Pharmacological characterization of GABAA receptors in taurine-fed mice

Journal of Biomedical Science

Volumn 17, Issue SUPPL. 1, 2010, Pages

  Lamoreaux, William J ^a,b   Marsillo, Alexandra ^a   El Idrissi, Abdeslem ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; PICROTOXIN; TAURINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIORAL SCIENCE; CONFERENCE PAPER; CONTROLLED STUDY; DIET; DISEASE DURATION; DRUG BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEIZURE; SURVIVAL RATE; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM;

ANIMALIA; MUS;

ANIMALS; BEHAVIOR, ANIMAL; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; MALE; MICE; PICROTOXIN; RECEPTORS, GABA-A; SEIZURES; TAURINE;

EID: 77956022245     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-S1-S14     Document Type: Conference Paper

References (36)

1. Regulation of gamma-aminobutyric acid synthesis in the brain. DL Martin K Rimvall, J Neurochem 1993 60 395 407 10.1111/j.1471-4159.1993.tb03165.x 8419527
2. Two isoforms of glutamate decarboxylase: why? JJ Soghomonian DL Martin, Trends Pharmacol Sci 1998 19 500 505 10.1016/S0165-6147(98)01270-X 9871412
3. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of Parkinsonian monkeys. JJ Soghomonian N Laprade, Synapse 1997 27 122 132 10.1002/(SICI)1098-2396(199710) 27:2<122::AID-SYN3>3.0.CO;2-G 9266773
4. Transient increase in expression of a glutamate decarboxylase (GAD) mRNA during the postnatal development of the rat striatum. KF Greif NJ Tillakaratne MG Erlander S Feldblum AJ Tobin, Dev Biol 1992 153 158 164 10.1016/0012-1606(92) 90100-U 1516745
5. Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis. G Battaglioli H Liu DL Martin, Journal of Neurochemistry 2003 86 879 887 10.1046/j.1471-4159.2003. 01910.x 12887686
6. Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. G Bowers WE Cullinan JP Herman, J Neurosci 1998 18 5938 5947 9671680
7. Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. M Esclapez CR Houser, J Comp Neurol 1999 412 488 505 10.1002/(SICI)1096-9861(19990927)412:3<488::AID-CNE8>3.0.CO;2-6 10441235
8. Isonicotinic acid hydrazide-induced changes in the metabolism of gamma-aminobutyric acid in the brain of four species. RE Casey JD Wood, Comp Biochem Physiol B 1973 45 741 748 10.1016/0305-0491(73)90135-1 4737979
9. Endogenous gamma-hydroxybutyrate in rat brain areas: postmortem changes and effects of drugs interfering with gamma-aminobutyric acid metabolism. M Eli F Cattabeni, J Neurochem 1983 41 524 530 10.1111/j.1471-4159.1983.tb04770.x 6875551
10. Selective susceptibility to inhibitors of GABA synthesis and antagonists of GABA(A) receptor in rats with genetic absence epilepsy. M Vergnes A Boehrer S Reibel S Simler C Marescaux, Exp Neurol 2000 161 714 723 10.1006/exnr.1999.7302 10686090
11. Epileptogenic drugs: a systematic review. C Ruffmann G Bogliun E Beghi, Expert Rev Neurother 2006 6 575 589 10.1586/14737175.6.4.575 16623656
12. Selective resistance of taurine-fed mice to isoniazide-potentiated seizures: in vivo functional test for the activity of glutamic acid decarboxylase. A El Idrissi WJ L'Amoreaux, Neuroscience 2008 156 693 699 10.1016/j.neuroscience.2008.07.055 18727952
13. Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. G Sperk H Lassmann H Baran F Seitelberger O Hornykiewicz, Brain Res 1985 338 289 295 10.1016/0006-8993(85) 90159-3 4027598
14. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Y Ben-Ari, Neuroscience 1985 14 375 403 10.1016/0306-4522(85)90299-4 2859548
15. 'Status epilepticus. I: Pathogenesis'. CJ Bruton, Dev Med Child Neurol 1993 35 277 8462764
16. Taurine in the central nervous system and the mammalian actions of taurine. RJ Huxtable, Prog Neurobiol 1989 32 471 533 10.1016/0301-0082(89)90019- 1 2664881
17. Interrelationship between taurine and GABA. K Kuriyama T Hashimoto, Adv Exp Med Biol 1998 442 329 337 9635048
18. Taurine in development. JA Sturman, Physiol Rev 1993 73 119 147 8419963
19. Taurine as a modulator of excitatory and inhibitory neurotransmission. A El Idrissi E Trenkner, Neurochem Res 2004 29 189 197 10.1023/B:NERE.0000010448. 17740.6e 14992278
20. Taurine allosterically inhibits binding of [35S]-t- butylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes. MR Quinn CL Harris, Neuropharmacology 1995 34 1607 1613 10.1016/0028-3908(95)00118-2 8788958
21. Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain. M Frosini C Sesti S Dragoni M Valoti M Palmi HB Dixon F Machetti G Sgaragli, Br J Pharmacol 2003 138 1163 1171 10.1038/sj.bjp.0705134 12684273
22. Taurine receptor: kinetic analysis and pharmacological studies. JY Wu XW Tang WH Tsai, Adv Exp Med Biol 1992 315 263 268 1324594
23. Strain differences in picrotoxin seizure threshold. GS Burt, Nature 1962 193 301 302 10.1038/193301a0 13875057
24. Convulsions and the gamma-aminobutyric acid content of rat brain. FV DeFeudis KA Elliott, Can J Physiol Pharmacol 1968 46 803 804 5681539
25. Some correlations between picrotoxin-induced seizures and gamma-aminobutyric acid in animal brain. S Saito Y Tokunaga, J Pharmacol Exp Ther 1967 157 546 554 6048015
26. Taurine improves learning and retention in aged mice. A El Idrissi, Neurosci Lett 2008 436 19 22 10.1016/j.neulet.2008.02.070 18375059
27. Functional implication of taurine in aging. A El Idrissi L Boukarrou K Splavnyk E Zavyalova EF Meehan W L'Amoreaux, Adv Exp Med Biol 2009 643 199 206 full-text 19239150
28. Prevention of epileptic seizures by taurine. A El Idrissi J Messing J Scalia E Trenkner, Adv Exp Med Biol 2003 526 515 525 12908638
29. Inhibitory effects of motilin, somatostatin, [Leu]enkephalin, [Met]enkephalin, and taurine on neurons of the lateral vestibular nucleus: interactions with gamma-aminobutyric acid. V Chan-Palay M Ito P Tongroach M Sakurai S Palay, Proc Natl Acad Sci U S A 1982 79 3355 3359 10.1073/pnas.79.10. 3355 6124970
30. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. PR Louzada AC Lima DL Mendonca-Silva F Noel FG De Mello ST Ferreira, Faseb J 2004 18 511 518 10.1096/fj.03-0739com 15003996
31. Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. L Chen KA Durkin JE Casida, Proc Natl Acad Sci U S A 2006 103 5185 5190 10.1073/pnas.0600370103 16537435
32. Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. N Hussy C Deleuze MG Desarmenien FC Moos, Prog Neurobiol 2000 62 113 134 10.1016/S0301-0082(99)00071- 4 10828380
33. Osmotic sensitivity of taurine release from hippocampal neuronal and glial cells. JE Olson GZ Li, Adv Exp Med Biol 2000 483 213 218 full-text 11787600
34. Role of osmoregulation in the actions of taurine. S Schaffer K Takahashi J Azuma, Amino Acids 2000 19 527 546 10.1007/s007260070004 11140357
35. Brain osmolyte content and blood-brain barrier water permeability surface area product in osmotic edema. JE Olson JA Evers M Banks, Acta Neurochir Suppl (Wien) 1994 60 571 573 7976653
36. A possible role for taurine in osmoregulation within the brain. JV Wade JP Olson FE Samson SR Nelson TL Pazdernik, J Neurochem 1988 51 740 745 10.1111/j.1471-4159.1988.tb01807.x 3411323